Chimovits Erez
SEC insider (Form 3/4/5 filer). CIK 0001706399. Director at ADARx Pharmaceuticals, Inc. (ADRX) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in SAN DIEGO, CA.
Companies Chimovits Erez has filed insider reports for
- ADARx Pharmaceuticals, Inc. (ADRX): Director
- Braveheart Bio, Inc. (BRVE): Director, 10% Owner
- Upstream Bio, Inc. (UPB): Director
Chimovits Erez
CIK: 0001706399
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 7, 2026BRVE
Braveheart Bio, Inc.
PurchaseIndirect1.7M shares at avg. $18.00$30.0M - Aug 7, 2026BRVE
Braveheart Bio, Inc.
PurchaseIndirect273.3K shares at avg. $18.00$4.9M - Aug 7, 2026BRVE
Braveheart Bio, Inc.
ConversionIndirect9.1M shares- - Aug 5, 2026BRVE
Braveheart Bio, Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - Jun 9, 2026UPB
Upstream Bio, Inc.
AwardDirectStock Option (Right to Buy)
17.1K shares- - Jun 10, 2025UPB
Upstream Bio, Inc.
AwardDirectStock Option (Right to Buy)
17.1K shares- - Oct 15, 2024UPB
Upstream Bio, Inc.
ConversionIndirect2.9M shares- - Oct 15, 2024UPB
Upstream Bio, Inc.
ConversionIndirect722K shares- - Oct 15, 2024UPB
Upstream Bio, Inc.
PurchaseIndirect165K shares at avg. $17.00$2.8M - Oct 15, 2024UPB
Upstream Bio, Inc.
PurchaseIndirect660K shares at avg. $17.00$11.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  BRVE Braveheart Bio, Inc. | Purchase | 1,666,667 | $18.00 | $30,000,006 | Indirect |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Purchase | 273,333 | $18.00 | $4,919,994 | Indirect |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Conversion | 9,132,420 | - | $0 | Indirect |
| Aug 5, 2026 | BRVE Braveheart Bio, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Jun 9, 2026 |  UPB Upstream Bio, Inc. | Award Stock Option (Right to Buy) | 17,096 | - | - | Direct |
| Jun 10, 2025 | UPB Upstream Bio, Inc. | Award Stock Option (Right to Buy) | 17,096 | - | - | Direct |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Conversion | 2,887,833 | - | $0 | Indirect |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Conversion | 721,956 | - | $0 | Indirect |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Purchase | 165,000 | $17.00 | $2,805,000 | Indirect |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Purchase | 660,000 | $17.00 | $11,220,000 | Indirect |
1-10 of 11 transactions